Skip to main content
Canada’s most-awarded newsroom for a reason
Enjoy unlimited digital access
$1.99
per week
for 24 weeks
Canada’s most-awarded newsroom for a reason
$1.99
per week
for 24 weeks
// //

Illumina Inc NASDAQ: ILMN-Q

Today's Change
Volume
Real-Time Last Update Last Sale Cboe BZX Real-Time

Today's Trading

Day Low 431.38
Day High 436.69
Open:436.69
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

More stories below advertisement

Description
Illumina, Inc. is improving human health by unlocking the power of the genome. Their focus on innovation has established them as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. Their products are used for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments.

Fundamentals

Market Capitalization, $K
Shares Outstanding, K
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio
Price/Book

Earnings

Corporate earnings are provided from Zacks Investment Research, including Income Statements, Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research.

Hold

StockReports+

A premium report that provides detailed quantitative assessments of earnings, fundamentals, relative valuation, risk, price momentum and more. For subscribers only.

StockCalc

What is this stock worth in intrinsic value? View this premium StockCalc report to see this stock's valuation and how it was calculated using fundamental analysis. For subscribers only.

ValuEngine

A stock valuation and forecasting report include rating, fair value assessment, return forecasts, market ratio-based valuations and comparable analysis. Available for free with registration.

Latest Press Releases

Illumina Ventures Closes $325 Million Fund
- Business Wire - Mon Sep 20, 7:00AM CDT
Business Wire - CMTX
Mon Sep 20, 7:00AM CDT
Illumina Ventures, an independently-managed, healthcare-focused venture firm, announced today the closing of its second investment fund with total commitments of $325 million, bringing its total capital under management to $560 million. The latest fund is anchored by Illumina, Inc. (Nasdaq: ILMN), with the majority of the total committed capital from other strategic and financial investors, including the Ireland Strategic Investment Fund (ISIF). The fund will support early-stage companies that are pioneering breakthroughs in life science tools, clinical diagnostics, therapeutics platforms, digital health, and other applications of genomics.
Illumina Accelerator Invests in Seven Genomics Startups for Third Global Cycle
- PR Newswire - PRF - Wed Sep 15, 8:15AM CDT
PR Newswire - PRF - CMTX
Wed Sep 15, 8:15AM CDT
/PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) has selected seven new genomics companies to join the third global funding cycle of . The global company creation engine, focused on partnering with entrepreneurs to build breakthrough genomics startups, invested in four companies for the 3 funding cycle of Illumina Accelerator and three companies for the 13 funding cycle of Illumina Accelerator San Francisco Bay Area.
Single Cell Genome Sequencing Market: Product Specification, Share, Size, Emerging Trends, Competitive Analysis and Forecast 2028
- AmericaNewsHour - Wed Sep 15, 2:57AM CDT
AmericaNewsHour - CMTX
Wed Sep 15, 2:57AM CDT
Research Nester published a report titled which delivers detailed overview of the global single cell genome sequencingmarket in terms of market segmentation by product, application, end user and by region.
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 431.38 +0.74% increase
on 09/22/21
Period Open:486.71
Price movement based on the high, low and last over the given period.
492.29 -11.72% decrease
on 08/23/21
-52.12 (-10.71%) decrease
since 08/20/21
3-Month 431.38 +0.74% increase
on 09/22/21
Period Open:465.69
Price movement based on the high, low and last over the given period.
526.00 -17.38% decrease
on 08/16/21
-31.10 (-6.68%) decrease
since 06/22/21
52-Week 267.10 +62.71% increase
on 09/24/20
Period Open:268.51
Price movement based on the high, low and last over the given period.
555.77 -21.80% decrease
on 02/12/21
+166.08 (+61.85%) increase
since 09/22/20

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2021.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

© 2021 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies